Jane Street’s Soleno Therapeutics SLNO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-11,002
| Closed | -$368K | – | 12995 |
|
|
2026
Q1 | $368K | Sell |
11,002
-130,738
| -92% | -$5.13M | ﹤0.01% | 8761 |
|
|
2025
Q4 | $6.56M | Buy |
+141,740
| New | +$7.77M | ﹤0.01% | 2844 |
|
|
2025
Q3 | – | Sell |
-44,867
| Closed | -$3.33M | – | 11684 |
|
|
2025
Q2 | $3.76M | Buy |
44,867
+35,670
| +388% | +$2.67M | ﹤0.01% | 3405 |
|
|
2025
Q1 | $657K | Buy |
9,197
+2,923
| +47% | +$142K | ﹤0.01% | 6361 |
|
|
2024
Q4 | $282K | Sell |
6,274
-15,339
| -71% | -$795K | ﹤0.01% | 7836 |
|
|
2024
Q3 | $1.09M | Buy |
21,613
+7,543
| +54% | +$361K | ﹤0.01% | 5709 |
|
|
2024
Q2 | $574K | Sell |
14,070
-768
| -5% | -$32.5K | ﹤0.01% | 6790 |
|
|
2024
Q1 | $635K | Sell |
14,838
-30,618
| -67% | -$1.38M | ﹤0.01% | 6235 |
|
|
2023
Q4 | $1.83M | Buy |
+45,456
| New | +$1.29M | ﹤0.01% | 4481 |
|
|
2022
Q2 | – | Sell |
-933
| Closed | -$3K | – | 10767 |
|
|
2022
Q1 | $3K | Sell |
933
-395
| -30% | -$2.04K | ﹤0.01% | 10156 |
|
|
2021
Q4 | $8K | Buy |
+1,328
| New | +$13.9K | ﹤0.01% | 9923 |
|
|
2020
Q3 | – | Sell |
-3,771
| Closed | -$125K | – | 7850 |
|
|
2020
Q2 | $125K | Buy |
+3,771
| New | +$163K | ﹤0.01% | 6629 |
|
|
2015
Q2 | – | Sell |
-227
| Closed | -$109K | – | 3994 |
|
|
2015
Q1 | $109K | Buy |
+227
| New | +$67.4K | ﹤0.01% | 2992 |
|
Jane Street's SLNO Position: Q2 2026 in Review
Jane Street sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 11,002 shares — an estimated $368K sold.
Jane Street first reported a position in SLNO in Q1 2015 and held it in 13 quarters. The position peaked at $6.56M in Q4 2025. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.
- Jane Street reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
- Jane Street sold 11,002 Soleno Therapeutics shares in Q2 2026, an estimated $368K.
- Jane Street first reported a position in Soleno Therapeutics in Q1 2015 and held it in 13 quarters.
- Jane Street's Soleno Therapeutics position peaked at $6.56M in Q4 2025.
- 0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.
Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.